190 related articles for article (PubMed ID: 35670246)
21. [Selected biomarkers in the primary tumors of the central nervous system: short review].
Rychlý B; Grossmann P; Steňo A; Pataky F
Cesk Patol; 2012 Apr; 48(2):65-71. PubMed ID: 22716052
[TBL] [Abstract][Full Text] [Related]
22. [Integrated diagnostics of brain tumours based on histological and molecular features].
Petersen JK; Scheie D; Boldt HB; Ulhøi BP; Ettrup MS; Kristensen BW
Ugeskr Laeger; 2019 Feb; 181(6):. PubMed ID: 30729918
[TBL] [Abstract][Full Text] [Related]
23. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification.
Tran S; Bielle F
Curr Opin Oncol; 2022 Nov; 34(6):670-675. PubMed ID: 36093875
[TBL] [Abstract][Full Text] [Related]
24. DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classification.
Schmid K; Sehring J; Németh A; Harter PN; Weber KJ; Vengadeswaran A; Storf H; Seidemann C; Karki K; Fischer P; Dohmen H; Selignow C; von Deimling A; Grau S; Schröder U; Plate KH; Stein M; Uhl E; Acker T; Amsel D
Brain Pathol; 2024 May; 34(3):e13228. PubMed ID: 38012085
[TBL] [Abstract][Full Text] [Related]
25. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.
Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS
Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093
[TBL] [Abstract][Full Text] [Related]
27. The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.
Osborn AG; Louis DN; Poussaint TY; Linscott LL; Salzman KL
AJNR Am J Neuroradiol; 2022 Jul; 43(7):928-937. PubMed ID: 35710121
[TBL] [Abstract][Full Text] [Related]
28. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
29. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
[TBL] [Abstract][Full Text] [Related]
31. Miscellaneous newly recognized types of CNS tumors in the WHO CNS5 classification (other than gliomas, glioneuronal and embryonal tumors).
Chatterjee D; Gupta K
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S94-S98. PubMed ID: 35562139
[TBL] [Abstract][Full Text] [Related]
32. [Classical pathology and basic concepts of the current WHO classification (5th edition) of central nervous system tumors].
Scheich B; Rajnai H
Magy Onkol; 2023 Dec; 67(4):289-303. PubMed ID: 38109508
[TBL] [Abstract][Full Text] [Related]
33. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
Colen RR; Hassan I; Elshafeey N; Zinn PO
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
[TBL] [Abstract][Full Text] [Related]
34. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
35. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
36. Overview of recent advances in the classification of ependymomas in WHO CNS5 classification: Simplified approach to their integrated diagnosis.
Gupta RK; Sharma A; Sharma MC
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S68-S72. PubMed ID: 35562136
[TBL] [Abstract][Full Text] [Related]
37. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
Gestrich CK; Couce ME; Cohen ML
Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
[TBL] [Abstract][Full Text] [Related]
38. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
Pickles JC; Stone TJ; Jacques TS
J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
[TBL] [Abstract][Full Text] [Related]
39. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
Komori T
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
[TBL] [Abstract][Full Text] [Related]
40. Building diagnoses with four layers: WHO 2016 classification of CNS tumors.
Bielle F
Rev Neurol (Paris); 2016; 172(4-5):253-5. PubMed ID: 27210026
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
